Clinical Trials in Detroit

Showing 13301-13320 of 19,719 trials

Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors

NCT02319018

This phase I trial studies the side effects and best dose of alisertib when given together with combination chemotherapy in treating patients with gastrointestinal tumors. Alisertib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as fluorouracil, leucovorin calcium, oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving alisertib with more than one drug (combination chemotherapy) may be a better treatment for gastrointestinal tumors.

Malignant Digestive System Neoplasm

National Cancer Institute (NCI)14 participantsStarted Aug 2015

New Haven, Connecticut, United States • New Haven, Connecticut, United States • Baltimore, Maryland, United States +2 more locations

COMPLETEDNA< 1 mile

Substance Abuse Treatment to HIV Care (SAT2HIV): The Implementation & Sustainment Facilitation Experiment

NCT03120598

A cluster randomized experiment focused on testing the extent to which the organization-focused Implementation \& Sustainment Facilitation (ISF) strategy is an effective adjunct to the staff-focused Addiction Technology Transfer Center (ATTC) strategy.

Substance Use

RTI International190 participantsStarted Jan 2015

Phoenix, Arizona, United States • Claremont, California, United States • Irvine, California, United States +36 more locations

Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors

Substance Abuse Treatment to HIV Care (SAT2HIV): The Implementation & Sustainment Facilitation Experiment

Find Trials by Condition in Detroit

A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis With Hunner's Lesions

Reducing Inappropriate Benzodiazepine Use Among Older Adults

SC-002 in Small Cell Lung Cancer and Large Cell Neuroendocrine Carcinoma

Sevelamer for Reducing Endotoxemia and Immune Activation

30-Day Cardiac Event Monitor Belt for Recording Atrial Fibrillation After a Cerebral Ischemic Event

Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings

Safety and Immunogenicity of 2 or 3 Doses of MenACWY Conjugate Vaccine in Healthy Infants and the Effects of a Booster Dose of MenACWY Administered in the Second Year of Life

Effect of Aclidinium/Formoterol on Lung Hyperinflation, Exercise Capacity and Physical Activity in Moderate to Severe COPD Patients

Multicenter Continuous Peripheral Nerve Block Surveillance Study

Switchover Trial From Imiglucerase to Plant Cell Expressed Recombinant Human Glucocerebrosidase

Plant Cell Expressed Recombinant Human Glucocerebrosidase Extension Trial

Post-Market Study of the Modular Revision Hip System

A Study of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Stage I and Stage II Hypertension

Gastric Electrical Stimulation (GES) for the Treatment of Obesity

A Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris

Open-label Long-term Safety Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease Who Have Completed a Previous AT1001 Study

A Phase 1 Trial of a Single ProHema® CB Product for Pediatric Patients With Hematologic Malignancies